According to Kaplan–Meier plotter website, PILRA expression was positively associated with prognosis of cancer patients receiving immunotherapy, including anti-PD1, anti-PD-L1 and anti-CTLA-4 (Fig. 8F-G). The gene discussed is CTLA4; the disease is cancer.